The preparation of a complex of insulin-phospholipids and their interaction mechanism

Journal of Peptide Science

Volumn 18, Issue 9, 2012, Pages 541-548

  Zhou, Cuiping ^a   Xia, Xuejun ^a   Liu, Yuling ^a   Li, Lin ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Blood glucose; Hydrogen bond; Insulin phospholipids complex; Solvent evaporation

Indexed keywords

CHLOROFORM; DICHLOROMETHANE; ETHER; LIPOID S75; ORGANIC SOLVENT; PHOSPHOLIPID; RECOMBINANT HUMAN INSULIN; TETRAHYDROFURAN; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHEMICAL BOND; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; LIPID SOLUBILITY; LIPOPHILICITY; MALE; MICELLE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REACTION ANALYSIS; SOLVENT EVAPORATION METHOD;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; INSULIN; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; PHOSPHOLIPIDS; PROTEIN BINDING; SOLVENTS; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

MUS;

EID: 84865187695     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2423     Document Type: Article

References (23)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. New Engl. J. Med. 2007; 356(3): 213-215.
2. Wielandt JO, Niemeyer M, Hansen MR, Bucher D, Thomsen NB. An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opin. Drug Del. 2011; 8(10): 1271-1276.
3. Onuki Y, Morishita M, Takayama K. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J. Control. Release 2004; 97(1): 91-99.
4. Sintov AC, Levy HV, Botner S. Systemic delivery of insulin via the nasal route using a new microemulsion system: in vitro and in vivo studies. J. Control. Release 2010; 148(2): 168-176.
5. Niu M, Lu Y, Hovgaard L, Wu W. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int. J. Nanomedicine 2011; 6: 1155-1166.
6. Zhang N, Ping QN, Huang GH, Xu WF. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int. J. Pharm. 2005; 294(1-2): 247-259.
7. Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 2007; 8(10): 3054-3060.
8. Qian F, Cui F, Ding J, Tang C, Yin C. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization. Biomacromolecules 2006; 7(10): 2722-2727.
9. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011; 12(1): 10-20.
10. Morishita M, Khafagy ES, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Delivery Rev. 2007; 59(15): 1521-1546.
11. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32(1): 193-203.
12. Sindhu A, Bharath S, Furtado S, Deveswaran R, Basavaraj B. Development of and advances in insulin delivery. SA Pharm. J. 2011; 78(6): 32-37.
13. Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm. Res. 2011; 28(5): 962-977.
14. Pinholt C, Hostrup S, Bukrinsky JT, Frokjaer S, Jorgensen L. Influence of acylation on the adsorption of insulin to hydrophobic surfaces. Pharm. Res. 2011; 28(5): 1031-1040.
15. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J. Microencapsul. 1990; 7(3): 347-355.
16. Perez C, Castellanos IJ, Costantino HR, Al-Azzam W, Griebenow K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J. Pharm. Pharmacol. 2002; 54(3): 301-313.
17. Sharma CP, Ramesan RM. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev. Med. Devices 2009; 6(6): 665-676.
18. Iyer H, Khedkar A, Verma M. Oral insulin - a review of current status. Diabetes Obes. Metab. 2010; 12(3): 179-185.
19. Naga Sowjanyal J, Kiran Kumar Y, Das S, Pattanayak D. Phytosome a novel entity in herbal delivery system: a review. International J. Pharm. Res. Dev. 2010; 2(9): 153-164.
20. Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 2006; 307(1): 77-82.
21. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007; 330(1-2): 155-163.
22. Semalty A, Semalty M, Singh D, Rawat MSM. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J. Inclusion Phenom. Macrocyclic Chem. 2009; 67(3-4): 253-260.
23. Lu Y, Zhang Y, Yang Z, Tang X. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. Int. J. Pharm. 2009; 366(1-2): 160-169.